RecruitingPhase 3NCT07662109
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Elkhorn, NE · +39 more sites
1 recruiting studies have a site in or near Elkhorn, NE, Nebraska.
Showing 1 of 1 studies
Sponsor: AstraZeneca
Elkhorn, NE · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.